169 related articles for article (PubMed ID: 34518930)
41. Clinical study of six cases showing late relapse of germ cell tumors.
Muramaki M; Hara I; Miyake H; Yamada Y; Kawabata G; Kamidono S
Int J Urol; 2005 Sep; 12(9):855-8. PubMed ID: 16201988
[TBL] [Abstract][Full Text] [Related]
42. Management of Late Relapses After Chemotherapy in Testicular Cancer: Optimal Outcomes with Dose-intense Salvage Chemotherapy and Surgery.
Alifrangis C; Lucas O; Benafif S; Ansell W; Greenwood M; Smith S; Wilson P; Thomas B; Rudman S; Mazhar D; Berney D; Shamash J
Eur Urol Focus; 2021 Jul; 7(4):835-842. PubMed ID: 32381397
[TBL] [Abstract][Full Text] [Related]
43. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
[TBL] [Abstract][Full Text] [Related]
44. Primary mediastinal germ cell tumors in children and adolescents: results of the German cooperative protocols MAKEI 83/86, 89, and 96.
Schneider DT; Calaminus G; Reinhard H; Gutjahr P; Kremens B; Harms D; Göbel U
J Clin Oncol; 2000 Feb; 18(4):832-9. PubMed ID: 10673525
[TBL] [Abstract][Full Text] [Related]
45. Improved prognosis of patients with intermediate- and poor-risk nonseminomatous germ cell tumours by optimizing combined treatment.
Pentheroudakis G; De Bono JS; Kaye SB; Simpson A; Paul J; Brown I; Pamenter B; Kirk A; Vasey P; Raby N; Kirk D
BJU Int; 2003 Jul; 92(1):36-42. PubMed ID: 12823380
[TBL] [Abstract][Full Text] [Related]
46. Survival after an antiangiogenetic therapy and surgery in a wide spread growing teratoma originating from a testicular mixed malignant germ cell tumor.
Calaminus G; Schneider DT; Weissbach L; Schönberger S; Okpanyi V; Leuschner I; Poremba C; Göbel U
Klin Padiatr; 2009; 221(3):136-40. PubMed ID: 19437360
[TBL] [Abstract][Full Text] [Related]
47. [Early prediction of treatment response to high-dose chemotherapy in patients with relapsed germ cell tumors using [18F]FDG-PET, CT or MRI, and tumor marker].
Pfannenberg AC; Oechsle K; Kollmannsberger C; Dohmen BM; Bokemeyer C; Bares R; Vontheim R; Claussen CD
Rofo; 2004 Jan; 176(1):76-84. PubMed ID: 14712410
[TBL] [Abstract][Full Text] [Related]
48. Mature teratoma identified after postchemotherapy surgery in patients with disseminated nonseminomatous testicular germ cell tumors: a plea for an aggressive surgical approach.
Sonneveld DJ; Sleijfer DT; Koops HS; Keemers-Gels ME; Molenaar WM; Hoekstra HJ
Cancer; 1998 Apr; 82(7):1343-51. PubMed ID: 9529027
[TBL] [Abstract][Full Text] [Related]
49. Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 cases.
Mitchell PL; Al-Nasiri N; A'Hern R; Fisher C; Horwich A; Pinkerton CR; Shepherd JH; Gallagher C; Slevin M; Harper P; Osborne R; Mansi J; Oliver T; Gore ME
Cancer; 1999 May; 85(10):2232-44. PubMed ID: 10326703
[TBL] [Abstract][Full Text] [Related]
50. Disease relapse in patients with stage I nonseminomatous germ cell tumor of the testis on active surveillance.
Thompson PI; Nixon J; Harvey VJ
J Clin Oncol; 1988 Oct; 6(10):1597-603. PubMed ID: 2459319
[TBL] [Abstract][Full Text] [Related]
51. High-dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumours: outcomes and prognostic variables in a case series of 17 patients.
Lewin J; Dickinson M; Voskoboynik M; Collins M; Ritchie D; Toner G
Intern Med J; 2014 Aug; 44(8):771-8. PubMed ID: 24893627
[TBL] [Abstract][Full Text] [Related]
52. Etoposide and cisplatin chemotherapy for metastatic good-risk germ cell tumors.
Kondagunta GV; Bacik J; Bajorin D; Dobrzynski D; Sheinfeld J; Motzer RJ; Bosl GJ
J Clin Oncol; 2005 Dec; 23(36):9290-4. PubMed ID: 16361627
[TBL] [Abstract][Full Text] [Related]
53. Poor prognosis of retroperitoneal mixed extragonadal germ cell tumors in an HIV-infected man with severe immunosuppression and bilateral cryptorchidism: a case report.
Li R; Li H
BMC Cancer; 2019 Mar; 19(1):244. PubMed ID: 30885154
[TBL] [Abstract][Full Text] [Related]
54. Clinical outcomes and histological findings of patients with advanced metastatic germ cell tumors undergoing post-chemotherapy resection of retroperitoneal lymph nodes and residual extraretroperitoneal masses.
Nakamura T; Oishi M; Ueda T; Fujihara A; Nakanishi H; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
Int J Urol; 2015 Jul; 22(7):663-8. PubMed ID: 25847721
[TBL] [Abstract][Full Text] [Related]
55. Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection.
Djaladat H; Nichols C; Daneshmand S
Ann Surg Oncol; 2012 Jul; 19(7):2388-93. PubMed ID: 22395993
[TBL] [Abstract][Full Text] [Related]
56. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
[No Abstract] [Full Text] [Related]
57. Postchemotherapy Resection of Residual Mass in Nonseminomatous Germ Cell Tumor.
Ghodoussipour S; Daneshmand S
Urol Clin North Am; 2019 Aug; 46(3):389-398. PubMed ID: 31277733
[TBL] [Abstract][Full Text] [Related]
58. Prognosis after resection of residual masses following chemotherapy for metastatic nonseminomatous testicular cancer: a multivariate analysis.
Steyerberg EW; Keizer HJ; Zwartendijk J; Van Rijk GL; Van Groeningen CJ; Habbema JD; Stoter G
Br J Cancer; 1993 Jul; 68(1):195-200. PubMed ID: 8318413
[TBL] [Abstract][Full Text] [Related]
59. Treatment outcome and long-term follow-up of central nervous system germ cell tumor using upfront chemotherapy with subsequent photon or proton radiation therapy: a single tertiary center experience of 127 patients.
Hong KT; Lee DH; Kim BK; An HY; Choi JY; Phi JH; Cheon JE; Kang HJ; Kim SK; Kim JY; Park SH; Kim IH; Shin HY
BMC Cancer; 2020 Oct; 20(1):979. PubMed ID: 33036578
[TBL] [Abstract][Full Text] [Related]
60. Long-term Surveillance of Patients with Complete Response Following Chemotherapy for Metastatic Nonseminomatous Germ Cell Tumor.
Nason GJ; Jewett MAS; Bostrom PJ; Goldberg H; Hansen AR; Bedard PL; Sturgeon J; Warde P; Chung P; Anson-Cartwright L; Sweet J; Atenafu EG; O'Malley M; Hamilton RJ
Eur Urol Oncol; 2021 Apr; 4(2):289-296. PubMed ID: 32907779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
